Associated Papers
Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism.
Mazarico-Altisent I et al.
Journal of Endocrinological Investigation, 2023
Multiple endocrine neoplasia type 4: a new member of the MEN family.
Singeisen H et al.
Endocrine Connections, 2023
Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management.
Lavezzi E et al.
Frontiers in Endocrinology, 2022
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
Viotto D et al.
The Journal of Pathology, 2021
Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases.
Frederiksen A et al.
The Journal of Clinical Endocrinology and Metabolism, 2019
Landscape of CDKN1B Mutations in Luminal Breast Cancer and Other Hormone-Driven Human Tumors.
Cusan M et al.
Frontiers in Endocrinology, 2018
MEN4 and CDKN1B mutations: the latest of the MEN syndromes.
Alrezk R et al.
Endocrine-related Cancer, 2017
p27Kip1 and human cancers: A reappraisal of a still enigmatic protein.
Bencivenga D et al.
Cancer Letters, 2017
A Possible New Multiple Endocrine Neoplasia Mutation in a Patient with a Prototypic Multiple Endocrine Neoplasia Presentation.
Buzzola R et al.
Cardiorenal Medicine, 2016
The unpredictable consequences of CDKN1B/p27Kip1 mutations in cancer.
Borriello A et al.
Cell Cycle (georgetown, Tex.), 2015
CanDrA: cancer-specific driver missense mutation annotation with optimized features.
Mao Y et al.
Plos One, 2013
Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.
Tichomirowa MA et al.
Endocrine-related Cancer, 2012
p27kip1: a new multiple endocrine neoplasia gene?
Marinoni I et al.
Neuroendocrinology, 2011
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization.
Molatore S et al.
Human Mutation, 2010
MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations.
Georgitsi M
Best Practice & Research. Clinical Endocrinology & Metabolism, 2010
Familial isolated pituitary adenoma: evidence for genetic heterogeneity.
Toledo RA et al.
Frontiers of Hormone Research, 2010
Familial pituitary adenomas.
Tichomirowa MA et al.
Journal of Internal Medicine, 2009